{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:13:07Z","timestamp":1792181587518,"version":"4.4.0"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"10","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA286210"],"award-info":[{"award-number":["R21CA286210"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015582","name":"Ovarian Cancer Academy","doi-asserted-by":"publisher","award":["OC230061"],"award-info":[{"award-number":["OC230061"]}],"id":[{"id":"10.13039\/100015582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["P30CA118100"],"award-info":[{"award-number":["P30CA118100"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 5CA99908-22"],"award-info":[{"award-number":["R01 5CA99908-22"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA210610"],"award-info":[{"award-number":["CA210610"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The NOTCH pathway regulates cell proliferation, differentiation, and stem cell maintenance. Thus, aberrant NOTCH activation plays a key role in cancer initiation, progression, and chemoresistance. Mutations and amplification of NOTCH pathway genes have been identified in high-grade serous ovarian cancers and are associated with poor clinical outcomes. Among the four NOTCH receptors, NOTCH3 alterations were strongly correlated with poor overall survival. Previously, we identified auranofin, an oral gold salt therapeutic compound, as a novel NOTCH pathway inhibitor that disrupts the DNA binding of RBPJ, the major downstream transcriptional effector of the NOTCH pathway. In this study, we surveyed the response of eight ovarian cancer cell lines to auranofin and found IC50 values ranging from 1.7 to 12 \u03bcmol\/L, with NOTCH3-negative SKOV3 cells having the highest IC50 value. In NOTCH-dependent OVCAR3 cells, auranofin synergized with cisplatin to enhance cell death. Importantly, auranofin treatment led to a dose-dependent decrease in RBPJ occupancy at the NOTCH-dependent promoters, HES1 and HES4. Furthermore, knocking down NOTCH3 in OVCAR3 cells significantly decreased sensitivity to auranofin, further supporting the notion that NOTCH3 signaling is a major target of auranofin. Moreover, auranofin increased cisplatin efficacy in an OVCAR3-derived xenograft mouse model. Using eight patient-derived cancer organoid models, we found that auranofin increased cisplatin efficacy in killing cancer organoids generated from clinically platinum-sensitive patients but also restored platinum response in a subset of organoid models developed from platinum-resistant patients. These studies underscore the potential of auranofin to improve platinum-based cancer therapy, particularly in NOTCH3-expressing cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>NOTCH signaling underlies cancer initiation, progression, and chemoresistance. Our study revealed the potential of auranofin as a NOTCH pathway inhibitor to enhance the efficacy of platinum-based ovarian cancer therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0190","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:43:43Z","timestamp":1758635023000},"page":"1796-1808","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Auranofin Synergizes with Cisplatin in Reducing Tumor Burden of NOTCH-Dependent Ovarian Cancer"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7196-5710","authenticated-orcid":false,"given":"Robert J.","family":"Lake","sequence":"first","affiliation":[{"name":"1Program in Cell and Molecular Oncology, University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Science Center, Albuquerque, New Mexico."},{"name":"2Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6954-7544","authenticated-orcid":false,"given":"Parisa","family":"Nikeghbal","sequence":"additional","affiliation":[{"name":"3Biomedical Sciences Graduate Program, University of New Mexico Health Science Center, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9538-4008","authenticated-orcid":false,"given":"Irina V.","family":"Lagutina","sequence":"additional","affiliation":[{"name":"4Animal Models Shared Resource, Comprehensive Cancer Center, University of New Mexico, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2704-8990","authenticated-orcid":false,"given":"Kimberly K.","family":"Leslie","sequence":"additional","affiliation":[{"name":"1Program in Cell and Molecular Oncology, University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Science Center, Albuquerque, New Mexico."},{"name":"2Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1226-9325","authenticated-orcid":false,"given":"Mara P.","family":"Steinkamp","sequence":"additional","affiliation":[{"name":"1Program in Cell and Molecular Oncology, University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Science Center, Albuquerque, New Mexico."},{"name":"5Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1790-4041","authenticated-orcid":false,"given":"Hua-Ying","family":"Fan","sequence":"additional","affiliation":[{"name":"1Program in Cell and Molecular Oncology, University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Science Center, Albuquerque, New Mexico."},{"name":"2Division of Molecular Medicine, Department of Internal Medicine, University of New Mexico Health Science Center, Albuquerque, New Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"2025101005403217000_bib1","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.ccell.2024.08.016","article-title":"Ovarian cancer metastasis: looking beyond the surface","volume":"42","author":"Bayraktar","year":"2024","journal-title":"Cancer Cell"},{"key":"2025101005403217000_bib2","doi-asserted-by":"crossref","first-page":"102571","DOI":"10.1016\/j.ctrv.2023.102571","article-title":"Treatments for relapsed, BRCA-wild type, platinum-sensitive ovarian cancer: a systematic review and network meta-analysis","volume":"118","author":"Petrelli","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"2025101005403217000_bib3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1158\/1078-0432.CCR-14-0809","article-title":"Molecular pathways: translational and therapeutic implications of the Notch signaling pathway in cancer","volume":"21","author":"Previs","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2025101005403217000_bib4","first-page":"228","article-title":"Notch and hedgehog signaling unveiled: crosstalk, roles, and breakthroughs in cancer stem cell Research","volume":"15","author":"Iluta","year":"2025","journal-title":"Life (Basel)"},{"key":"2025101005403217000_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3390\/cancers17030382","article-title":"Deciphering the role of cancer stem cells: drivers of tumor evolution, therapeutic resistance, and precision medicine strategies","volume":"17","author":"El-Tanani","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2025101005403217000_bib6","doi-asserted-by":"crossref","first-page":"e710","DOI":"10.1002\/mco2.710","article-title":"Intricate relationship between cancer stemness, metastasis, and drug resistance","volume":"5","author":"Dakal","year":"2024","journal-title":"MedComm (2020)"},{"key":"2025101005403217000_bib7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41580-025-00835-2","article-title":"Modes of Notch signalling in development and disease","volume":"26","author":"Bray","year":"2025","journal-title":"Nat Rev Mol cell Biol"},{"key":"2025101005403217000_bib8","doi-asserted-by":"crossref","first-page":"1542967","DOI":"10.3389\/fcell.2025.1542967","article-title":"Notch signaling in cancers: mechanism and potential therapy","volume":"13","author":"Chen","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"2025101005403217000_bib9","doi-asserted-by":"crossref","first-page":"1277076","DOI":"10.3389\/fcell.2023.1277076","article-title":"Metastasis and cancer associated fibroblasts: taking it up a NOTCH","volume":"11","author":"Ghosh","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"2025101005403217000_bib10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2025101005403217000_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"The Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"2025101005403217000_bib12","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1158\/0008-5472.CAN-13-2066","article-title":"Notch3 pathway alterations in ovarian cancer","volume":"74","author":"Hu","year":"2014","journal-title":"Cancer Res"},{"key":"2025101005403217000_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/biomedicines13020441","article-title":"Integrative analysis of gene expression and promoter methylation to differentiate high-grade serous ovarian cancer from benign tumors","volume":"13","author":"Vaicekauskait\u0117","year":"2025","journal-title":"Biomedicines"},{"key":"2025101005403217000_bib14","doi-asserted-by":"crossref","first-page":"E2939","DOI":"10.1073\/pnas.1206400109","article-title":"Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy","volume":"109","author":"McAuliffe","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025101005403217000_bib15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1158\/1541-7786.MCR-14-0334","article-title":"Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2","volume":"13","author":"Brown","year":"2015","journal-title":"Mol Cancer Res"},{"key":"2025101005403217000_bib16","first-page":"6264931","article-title":"Notch3 targeting: a novel weapon against ovarian cancer stem cells","volume":"2019","author":"Ceccarelli","year":"2019","journal-title":"Stem Cell Int"},{"key":"2025101005403217000_bib17","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.7150\/jca.18955","article-title":"Correlation of ALDH1 and Notch3 expression: clinical implication in ovarian carcinomas","volume":"8","author":"Kim","year":"2017","journal-title":"J Cancer"},{"key":"2025101005403217000_bib18","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.3390\/cancers13205106","article-title":"Targeting Notch to maximize chemotherapeutic benefits: rationale, advanced strategies, and future perspectives","volume":"13","author":"Zhdanovskaya","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025101005403217000_bib19","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.21037\/atm-20-4497","article-title":"NOTCH signalling in ovarian cancer angiogenesis","volume":"8","author":"Perez-Fidalgo","year":"2020","journal-title":"Ann Transl Med"},{"key":"2025101005403217000_bib20","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/cells9061503","article-title":"Top Notch targeting strategies in cancer: a detailed overview of recent insights and current perspectives","volume":"9","author":"Moore","year":"2020","journal-title":"Cells"},{"key":"2025101005403217000_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-biophys-101920-082204","article-title":"Biophysics of Notch signaling","volume":"50","author":"Sprinzak","year":"2021","journal-title":"Annu Rev Biophys"},{"key":"2025101005403217000_bib22","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1111\/febs.16815","article-title":"Notch signalling: multifaceted role in development and disease","volume":"291","author":"Sachan","year":"2024","journal-title":"FEBS J"},{"key":"2025101005403217000_bib23","doi-asserted-by":"crossref","first-page":"652273","DOI":"10.3389\/fcell.2021.652273","article-title":"Biological significance of NOTCH signaling strength","volume":"9","author":"Shen","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025101005403217000_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-pathol-052016-100127","article-title":"The varied roles of Notch in cancer","volume":"12","author":"Aster","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"2025101005403217000_bib25","doi-asserted-by":"crossref","first-page":"649205","DOI":"10.3389\/fcell.2021.649205","article-title":"Therapeutic targeting of Notch signaling: from cancer to inflammatory disorders","volume":"9","author":"Allen","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025101005403217000_bib26","doi-asserted-by":"crossref","first-page":"e608","DOI":"10.1002\/onco.13627","article-title":"Gamma secretase inhibitors in cancer: a current perspective on clinical performance","volume":"26","author":"McCaw","year":"2021","journal-title":"Oncologist"},{"key":"2025101005403217000_bib27","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature08543","article-title":"Direct inhibition of the NOTCH transcription factor complex","volume":"462","author":"Moellering","year":"2009","journal-title":"Nature"},{"key":"2025101005403217000_bib28","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/0008-5472.CAN-16-0061","article-title":"The small molecule IMR-1 inhibits the Notch transcriptional activation complex to suppress tumorigenesis","volume":"76","author":"Astudillo","year":"2016","journal-title":"Cancer Res"},{"key":"2025101005403217000_bib29","doi-asserted-by":"crossref","first-page":"16292","DOI":"10.1073\/pnas.1922606117","article-title":"Pharmacological disruption of the Notch transcription factor complex","volume":"117","author":"Lehal","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025101005403217000_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/2472555220932552","article-title":"A novel flow cytometric assay to identify inhibitors of RBPJ-DNA interactions","volume":"25","author":"Lake","year":"2020","journal-title":"SLAS Discov"},{"key":"2025101005403217000_bib31","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1093\/nar\/gkz178","article-title":"HDAC1 negatively regulates selective mitotic chromatin binding of the Notch effector RBPJ in a KDM5A-dependent manner","volume":"47","author":"Dreval","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2025101005403217000_bib32","doi-asserted-by":"crossref","first-page":"e1003407","DOI":"10.1371\/journal.pgen.1003407","article-title":"ATP-dependent chromatin remodeling by Cockayne syndrome protein B and NAP1-like histone chaperones is required for efficient transcription-coupled DNA repair","volume":"9","author":"Cho","year":"2013","journal-title":"Plos Genet"},{"key":"2025101005403217000_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"2025101005403217000_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1158\/2767-9764.CRC-22-0300","article-title":"Humanized patient-derived xenograft models of disseminated ovarian cancer recapitulate key aspects of the tumor immune environment within the peritoneal cavity","volume":"3","author":"Steinkamp","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2025101005403217000_bib35","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.3390\/cancers13122901","article-title":"Successful patient-derived organoid culture of gynecologic cancers for disease modeling and drug sensitivity testing","volume":"13","author":"Bi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2025101005403217000_bib36","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.1007\/s00018-016-2277-z","article-title":"Hes1: the maestro in neurogenesis","volume":"73","author":"Dhanesh","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"2025101005403217000_bib37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ygyno.2020.01.042","article-title":"Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: the SIERRA open-label phase Ib trial","volume":"157","author":"Coleman","year":"2020","journal-title":"Gynecol Oncol"},{"key":"2025101005403217000_bib38","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/art.41748","article-title":"Notch-1 and Notch-3 mediate hypoxia-induced activation of synovial fibroblasts in rheumatoid arthritis","volume":"73","author":"Chen","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025101005403217000_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","article-title":"Notch signalling drives synovial fibroblast identity and arthritis pathology","volume":"582","author":"Wei","year":"2020","journal-title":"Nature"},{"key":"2025101005403217000_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12672-021-00439-0","article-title":"The gold complex auranofin: new perspectives for cancer therapy","volume":"12","author":"Abdalbari","year":"2021","journal-title":"Discov Oncol"},{"key":"2025101005403217000_bib41","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/med.21872","article-title":"Upgrade of an old drug: auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness","volume":"42","author":"Gamberi","year":"2022","journal-title":"Med Res Rev"},{"key":"2025101005403217000_bib42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/10428194.2018.1509317","article-title":"Oxidative stress in chronic lymphocytic leukemia: still a matter of debate","volume":"60","author":"D\u2019Arena","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"2025101005403217000_bib43","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/onc.2016.224","article-title":"PKC\u03b9 regulates nuclear YAP1 localization and ovarian cancer tumorigenesis","volume":"36","author":"Wang","year":"2017","journal-title":"Oncogene"},{"key":"2025101005403217000_bib44","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ncb3555","article-title":"Dll4 and Notch signalling couples sprouting angiogenesis and artery formation","volume":"19","author":"Pitulescu","year":"2017","journal-title":"Nat Cell Biol"},{"key":"2025101005403217000_bib45","doi-asserted-by":"crossref","first-page":"642352","DOI":"10.3389\/fcell.2021.642352","article-title":"Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective","volume":"9","author":"Akil","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2025101005403217000_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1535-7163.MCT-22-0243","article-title":"Targeting the DLL\/Notch signaling pathway in cancer: challenges and advances in clinical development","volume":"22","author":"You","year":"2023","journal-title":"Mol Cancer Ther"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0190\/3654401\/crc-25-0190.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/10\/1796\/3658858\/crc-25-0190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/10\/1796\/3658858\/crc-25-0190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:40:41Z","timestamp":1760089241000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/10\/1796\/766145\/Auranofin-Synergizes-with-Cisplatin-in-Reducing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0190","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.30328461","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328482","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328470","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328491","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328458","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328446","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328479","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328467","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328455","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328488","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328476","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328443","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328464","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328485","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328473","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30328449","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8082255","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}